HANOI, 27 June 2014 – Three workshops on intellectual property, public health and local pharmaceutical production were held in Viet Nam in the course of the last two weeks.
Organized by the United Nations Industrial Development Organization (UNIDO), the UN Conference on Trade and Development (UNCTAD), and the Viet Nam Pharmaceutical Companies Association (VNCPA), the workshops were held in Ho Chi Minh City (from 16 to 17), Can Tho City (from 19 to 20 June), and in Hanoi (from 26 to 27 June).
The workshops were designed for local pharmaceutical manufacturers and other stakeholders interested in the impact of enforcement of intellectual property rights on producers of generic medicines. They examined how patents restrict the market space open to generic manufacturers, and how these manufacturers can use flexibilities contained under the international agreements and Vietnamese domestic laws to pursue the production of affordable high quality generic medicines.
Patrick Gilabert, UNIDO Representative to Viet Nam, said: “One issue of concern is the potential impact of intellectual property provisions on access to medicines, and the domestic pharmaceutical industry. The scope of the intellectual property chapter in a Free Trade Agreement (FTA) is very important for countries that have a generic pharmaceutical industry. Certain intellectual property provisions in FTAs may limit the ‘flexibilities’ contained in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)”.
The workshops included presentations by Christoph Spennemann, a legal expert from the Intellectual Property Unit of UNCTAD, and Huy Anh, Director of the Viet Nam Pharmaceutical Intellectual Property Department.
For more information, please contact:
Senior UNIDO Industrial Development Officer